Aoki, Ryo

Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis

Nakamoto, N., Sasaki, N., Aoki, R., Miyamoto, K., Suda, W., Teratani, T., Suzuki, T., Koda, Y., Chu, P.-S., Taniki, N., et al. (2019) · Nature Microbiology

Liver Diseases and ImmunityGut microbiota and health

Cited by 425

Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study

Nagata, N., Nishijima, S., Kojima, Y., Hisada, Y., Imbe, K., Miyoshi-Akiyama, T., Suda, W., Kimura, M., Aoki, R., Sekine, K., et al. (2022) · Gastroenterology

Gut microbiota and healthPancreatic and Hepatic Oncology Research

Cited by 209

Population-level Metagenomics Uncovers Distinct Effects of Multiple Medications on the Human Gut Microbiome

Nagata, N., Nishijima, S., Miyoshi-Akiyama, T., Kojima, Y., Kimura, M., Aoki, R., Ohsugi, M., Ueki, K., Miki, K., Iwata, E., et al. (2022) · Gastroenterology

Gut microbiota and healthAntibiotic Resistance in Bacteria

Cited by 178

Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice

Aoki, R., Onuki, M., Hattori, K., Ito, M., Yamada, T., Kamikado, K., Kim, Y.-G., Nakamoto, N., Kimura, I., Clarke, J. M., et al. (2021) · Microbiome

Gut microbiota and healthLiver Disease Diagnosis and Treatment

Cited by 167

Effects of administration of Bifidobacterium animalis subsp. lactis GCL2505 on defecation frequency and bifidobacterial microbiota composition in humans

Ishizuka, A., Tomizuka, K., Aoki, R., Nishijima, T., Saito, Y., Inoue, R., Ushida, K., Mawatari, T., & Ikeda, T. (2012) · Journal of Bioscience and Bioengineering

Probiotics and Fermented FoodsGut microbiota and health

Cited by 73